By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoMed Pharmaceuticals, Inc. 

800 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-995-8200 Fax: 650-298-8600


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
OncoMed Pharmaceuticals, Inc. (OMED) Presents Demcizumab Data From Phase 1b Clinical Trial In Non-Small Cell Lung Cancer Patients At The European Lung Cancer Conference 4/16/2015 9:01:32 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The Needham Healthcare Conference 4/10/2015 8:44:27 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present Clinical Data For Demcizumab At The European Lung Cancer Conference 4/9/2015 7:43:03 AM
OncoMed Pharmaceuticals, Inc. (OMED) And Eli Lilly (LLY) Enter Clinical Supply Agreement To Evaluate The Combination Of Demcizumab And Alimta (Pemetrexed For Injection) In Lung Cancer 4/2/2015 7:09:38 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present Data On Multiple Anti-Cancer Stem Cell Candidates At The American Association for Cancer Research Meeting 3/19/2015 7:48:33 AM
OncoMed Pharmaceuticals, Inc. (OMED) Reports Full Year And Fourth Quarter 2014 Financial Results And Recent Highlights 3/13/2015 7:21:41 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Report Full Year And Fourth Quarter 2014 Financial Results On Thursday, March 12, 2015 3/3/2015 8:27:19 AM
OncoMed Pharmaceuticals, Inc. (OMED) Initiates Dosing In Phase 2 Clinical Trial Of Demcizumab For The Treatment Of Non-Small Cell Lung Cancer 2/4/2015 7:36:32 AM
FDA Grants Orphan Drug Designations To OncoMed Pharmaceuticals, Inc. (OMED)'s Tarextumab For The Treatment Of Pancreatic And Small Cell Lung Cancer 1/29/2015 7:56:21 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The Biotechnology Industry Organization (BIO) CEO And Investor And Leerink Global Healthcare Conferences In February 1/28/2015 8:02:57 AM
12345678910...
//-->